The activation of this pathway elevates insulin-like growth factor-1 levels and alters signaling through peroxisome proliferator-activated receptor gamma and nuclear factor kappa B, contributing to CRC progression [22,23,24]. The gene discussed is IGF1; the disease is colorectal carcinoma.